Becton Dickinson to Pay $175 Million for Misleading Investors About Alaris Infusion Pump
Dec 16, 2024
The Securities and Exchange Commission today announced settled charges against Becton, Dickinson and Company, a New Jersey-based medical device manufacturer known as BD, for repeatedly misleading investors about risks associated with its continued sales…
Full report at: Read More
